Microinjections of nociceptin into the nucleus ambiguus elicit tachycardia in the rat

Cardiovascular effects of activation of opioid receptor like receptors (ORL1 receptors) in the nucleus ambiguus were studied in urethane-anesthetized, adult male Wistar rats. Microinjections of nociceptin (0.31, 0.62, 1.25 and 2.25 mmol/L) into the nucleus ambiguus elicited increases in heart rate (17.5 +/- 4, 33.3 +/- 2.9, 16.5 +/- 1.5 and 13.9 +/- 2.7 beats/min, respectively) which were blocked by an ORL1 receptor antagonist. These results indicate that activation of ORL1 receptors in the nucleus ambiguus elicits tachycardia.     

Oscillatory synchrony in the monkey temporal lobe correlates with performance in a visual short-term memory task

Oscillatory synchrony has been proposed to dynamically coordinate distributed neural ensembles, but whether this mechanism is effectively used in neural processing remains controversial. We trained two monkeys to perform a delayed matching-to-sample task using new visual shapes at each trial. Measures of population-activity patterns (cortical field potentials) were obtained from a chronically implanted array of electrodes placed over area V4 and posterior infero-temporal cortex. In correct trials, oscillatory phase synchrony in the beta range (15-20 Hz) was observed between two focal sites in the inferior temporal cortex while holding the sample in short-term memory. Error trials were characterized by an absence of oscillatory synchrony during memory maintenance. Errors did not seem to be due to an impaired stimulus encoding, since various parameters of neural activity in sensory area V4 did not differ in correct and incorrect trials during sample presentation. Our findings suggest that the successful performance of a visual short-term memory task depends on the strength of oscillatory synchrony during the maintenance of the object in short-term memory. The strength of oscillatory synchrony thus seems to be a relevant parameter of the neural population dynamics that matches behavioral performance.     

Congenital fibrolipoma of anal canal

Although rare, congenital lipomatosis presents during first few months of life as large sub-cutaneous fatty masses on chest with extension into skeletal muscle bundles. Only a few such cases have been reported in the literature. A rare case of congenital fibrolipoma of anal canal in a 3-day-old male child is being documented in the present report.     

Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody

Ibritumomab tiuxetan is a novel radioimmunotherapeutic agent that has a high response rate in relapsed or chemotherapy-refractory CD20+ B-cell non-Hodgkin's lymphoma. Whereas chemotherapy agents can successfully be used multiple times in a given patient, there are few data on the repeated use of radioimmunotherapy in terms of efficacy or morbidity, and no reports as yet involving radioconjugates that target different antigens We report on a patient who was treated successfully with yttrium-90-labeled humanized anti-CD22 monoclonal antibody (90Y-epratuzumab). Upon relapse 3 years later, the patient was treated again with radioimmunotherapy consisting of 90Y-ibritumomab tiuxetan anti-CD20 monoclonal antibody, with a good response and acceptable bone marrow suppression. This case report demonstrates the potential for repeated treatments with radioimmunotherapy agents in patients with chemotherapy-refractory non-Hodgkin's lymphoma.